|
|
505 Park Avenue 14th Floor
New York, NY 10022 USA
phone:
212-583-0370
fax:
212-826-9509 |
| Symbol |
Private |
| Founded |
2005 |
| Employees |
92 |
|
|
www.totalsmallbone.com |
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Implants for Small Bones and Joints |
 |
| Management |
| Anthony G. Viscogliosi, Chairman & CEO; Michael J. Simpson, President & COO; Steve Ward, Chief Financial Officer; Christopher DeNicola, Senior Vice President of Sales; Christopher J. Frederick, Senior Vice President, Worldwide Marketing |
|
|
|
|
| Keywords |
| Orthopedics, reconstruction, orthopedic, j2008b |
|
|
|
|
Description |
| Small Bone Innovations, LLC (SBI) was founded in 2004 by Viscogliosi Bros. LLC., a New York-based merchant banking firm that specializes in the musculoskeletal and orthopedic sectors. SBI's products and technologies assist physicians in treating small bones and joints in both the upper and lower extremities. |
 |
| Products / Services |
SBI, in conjunction with its developed and acquired companies, are involved in developing hand, wrist, elbow, arthroplasty and trauma products as well as implant manufacturing. The extensive product pipeline includes: the Avanta CMC implant, a "ball and socket" design used to treat basal joint arthritis of the thumb; the SR PIP (Proximal Interphalangeal) Implants, designed to replicate the anatomic joint surfaces, preserve bone and minimize disruption to the collateral ligament origins and insertions; the Diamond carpal fusion plate, for four corner fusion of the capitate, hamate, lunate and triquetrum bones in the hand; the rHead proximal radial head prosthesis; and the RingFIX, a modular external fixation system designed to accommodate patients with a large variety of clinical needs.
|
 |
| Technology / Differentiation |
| SBI has also acquired and developed companies specializing in porous metal technology, biologically active and biodegradable technology and resorbable trauma technology. |
 |
| Market / Customers |
Despite the dominance of hip and knee implant segments, clinicians and device manufacturers have nevertheless turned the small bone and joint market into a worldwide billion-dollar industry over the past few years. This figure is expected to double by 2011 to $2.0 billion.
|
 |
| Strategy |
Become the leading company in the small bone and joint space by offering a comprehensive line of technologies and services.
|
 |
| Funding |
| Viscogliosi Brothers LLC |
 |
| Status |
| The company was formally launched at the AAOS meeting February 2005. In January 2008, Small Bone Innovations entered into definitive agreements to acquire Link America, Inc., d/b/a Link Orthopaedics, The Scandinavian Total Ankle Replacement system, known as the S.T.A.R. Ankle, and certain assets related to the S.T.A.R. Ankle from Waldemar Link GmbH & Co. KG of Hamburg, Germany. SBI believes that if and when the Star Ankle device receives final approval by the FDA, the device will be the first and only FDA-approved, non-cemented mobile-bearing total ankle replacement prosthesis available to patients in the United States. |
 |
|
|
|
|